Media Resources

19 February

Pathogen Access and Benefit Sharing – HAI Statement to INB13

18 February

Statement to INB13 – Article 13

10 February

Statement to EB156 – Climate change and health

5 February

Statement to EB156 – NCDs

5 February

Statement to EB156 – UHC

28 November

INB 12 – HAI Statement

5 November

HAI Response to Public Consultation on EMA Policy 0044

31 May

Statement to WHA77 – Substance Use Disorder

30 May

Statement to WHA77 – Climate change and health

30 May

Statement to WHA77 – AMR: Accelerating national and global responses

29 May

Statement to WHA77- Universal Health Coverage

22 April

Statement to 8th Meeting of the WGIHR

18 March

INB 9 – HAI Statement

23 February

INB 8 – WGIHR – HAI Statement

19 February

INB 8 – HAI Statement

29 January

Statement to EB154 – Economics and Health for All

29 January

Statement to EB154 – Antimicrobial Resistance

24 January

Statement to EB154 – Universal Health Coverage

6 November

Statement to INB 7 on Pandemic PPR

28 September

HAI Response to EMA Real-World Evidence Consultation

21 September

HAI Response Public Consultation on EMA AI Reflection Paper

24 July

Statement to INB/IHR Plenary Session

12 June

Statement to the Fifth Meeting of the Intergovernmental Negotiating Body

26 May

Statement to WHA76 – UHC

24 May

Statement to WHA76 – Health Emergencies

19 April

Joint Statement on the Impact of Artificial Intelligence on Health Outcomes for Key Populations: Navigating Health Inequalities in the EU

31 March

Statement to US International Trade Commission Public Hearing on COVID-19

17 March

WHO EURO Access to Novel Medicines Platform

1 March

Statement following latest session of the European Parliament’s COVI Committee

27 February

Statement to the Fourth Meeting of the Intergovernmental Negotiating Body – Consideration and Negotiation of the Zero Draft of the WHO Convention